Great West Life Assurance CO Bellus Health Inc. Transaction History

Great West Life Assurance CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$0.0 - $14.75 $0 - $16,225	-1,100 Reduced 23.18%	3,646 $54,000
Q4 2022 Feb 10, 2023	BUY	$8.22 - $10.76 $15,938 - $20,863	1,939 Added 69.08%	4,746 $39,000
Q3 2022 Nov 01, 2022	BUY	$8.95 - $12.0 $25,122 - $33,684	2,807 New	2,807 $30,000
Q2 2022 Aug 09, 2022	BUY	$6.46 - $10.02 $18,133 - $28,126	2,807 New	2,807 $26,000
Q4 2020 Feb 16, 2021	SELL	$2.27 - $3.3 $7,883 - $11,460	-3,473 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$8.88 - $11.15 $30,840 - $38,723	3,473 New	3,473 $35,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.